StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
4958.T$3050.00-0.81%
Fair $3050.00+0.0%

4958.T

T. Hasegawa Co., Ltd.

Basic Materials / Specialty ChemicalsTokyo

$3050.00

-25.00 (-0.81%)

Fairly Valued+0.0%Fair Value $3050.00Fund rank 32/100 · Data gapFallback financials|
SA 45/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $6.6B · quality 59.3/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 72/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

45/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · 4958.TLocal privado en este navegador · T. Hasegawa Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$123.8B

P/E

17.2x

↓

EV/EBITDA

5.9x

↓

ROE

5.6%

↑

Gross Margin

41.3%

↑

Debt/Equity

N/A

•
52-Week Range$3050
$2651$3180

TradingView lightweight chart

4958.T price, volumen y niveles de valoración

Último $3,050Periodo +238.9%
Fair value: $3,050

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+5.6%

FCF CAGR

+19.4%

FCF margin

8.9%

FCF / Net income

0.95x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $73.50B · net income $6.92B · FCF $6.57B

2022-FY → 2025-FY

Gross margin

41.3%+0.2% pts

Operating margin

11.6%-1.3% pts

Net margin

9.4%-3.4% pts

FCF margin

8.9%+2.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$73.50B$73.50B$71.64B$64.87B$62.40B
Net Income$6.92B$6.92B$7.20B$6.67B$8.01B
EBITDA$15.24B$15.24B$15.21B$13.94B$15.50B
EPS168.63168.63174.27161.54193.97
Gross Margin41.3%41.3%41.4%39.6%41.1%
Operating Margin11.6%11.6%13.1%11.6%12.9%
Net Margin9.4%9.4%10.1%10.3%12.8%
Balance Sheet
Current Ratio5.335.33———
Cash Flow
Free Cash Flow$6.57B$6.57B$9.97B$4.46B$3.86B
Returns
ROE5.6%5.6%6.0%5.7%7.2%
Valuation
P/E17.1517.1519.3719.1617.12
EV/EBITDA5.935.937.377.327.53
P/B1.021.021.171.101.23
Growth & Yield
Revenue Growth2.6%2.6%10.4%4.0%—
EPS Growth-3.2%-3.2%7.9%-16.7%—
Dividend Yield3.3%3.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

17.1%

exigente

EPS terminal req.

$270.64

Spread vs growth

-20.3%

5Y implied EPS CAGR

14.2%

razonable

EPS terminal req.

$327.47

Spread vs growth

-17.4%

10Y implied EPS CAGR

12.1%

razonable

EPS terminal req.

$527.39

Spread vs growth

-15.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +10.3%

Total return

+10.3%

Start / end P/E

16.4x → 18.1x

EPS bridge

174.27 → 168.63

Residual

-0.3%

EPS growth-3.2%
Multiple rerating+10.6%
Dividend+3.3%
Residual / FX / buybacks / cross-term-0.3%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.